BHALLA NARINDER PAL (Chief Medical Officer) sold 21.3% of their position (22.31K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $98.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0002109299-26-000007
Officer· Chief Medical Officer
Since Feb 2026
+32.69K
Net shares
Net buyer
$98.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
55K acquired · 22.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+55K
Price / share
—
Trade value
—
% of position
111.1%
6/29/2026
49.50K→104.50K
Common Stock
Direct
Shares
−22.31K
Price / share
$4.42
Trade value
$98.59K
% of position
21.3%
7/1/2026
104.50K→82.19K
Total
Net shares
+32.69K
Net value
-$98.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | A · Award | +55K | — | — | 111.1% | 49.50K | 104.50K |
| Common Stock Direct | 7/1/2026 | S · Sale | −22.31K | $4.42 | $98.59K | 21.3% | 104.50K | 82.19K |
| Total | +32.69K | -$98.59K | ||||||
Derivative Transactions0
No derivative transactions reported